Gilberto De Castro Junior

Gilberto De Castro Junior

Universidade de São Paulo USP - São Paulo / Brazil
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 843980
University of São Paulo USP
person_outline Gilberto De Castro Junior's MOST POPULAR ARTICLES
1-) Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial,The Lancet 387 (10027), 1540-1550, 2016 -
2-) Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised …,The Lancet 394 (10212), 1915-1928, 2019 -
3-) Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients,British journal of cancer 96 (10), 1504-1513, 2007 -
4-) First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 studyJC Soria, DSW Tan, R Chiari, YL Wu, L Paz-Ares, J Wolf, SL Geater, ...The Lancet 389 (10072), 917-929, 201712492017
5-) Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30K Cocks, MT King, G Velikova, G de Castro Jr, MM St-James, PM Fayers, ...European journal of cancer 48 (11), 1713-1721, 20124732012